Mayo Clinic researchers combined the results of a functional test that measures the effect of inherited variants in the BRCA2 gene in breast and ovarian cancer with clinical information from women undergoing genetic testing to determine clinical significance for BRCA2. of many Variants of Unknown Meaning (VUS).
Read more
–
Related posts:
After Kane's poor penalty, Mbappé rushed to cheer and the English blamed the referee
Two young friends want to write history
Flu and Covid-19 Vaccination Campaign in Castilla y León: News, Administration, Doses, and Balance o...
COVID in Spain, last minute live | XE variant, masks, vaccines, strains...
